12.3.2 Time to Infection Presentation
Hardes et al. have reported that time to infection after insertion of a prosthesis can range from 1 to 70 months (mean, 16 months) [5]. I, along with my colleagues, have previously reported on 57 cases of infection following tumor-related endoprosthetic placement surgery, where time to infection from initial surgery ranged from 1 to 85 months. In this study, the mean period and median period to infection were 12.8 and 4 months, respectively, and of the total infections 26.3 % occurred more than 12 months after initial surgery [6].
In a study of 76 patients with allografts, six contracted infection. Of these infections, four developed during the early postoperative period, while the other two developed later and were considered to be chemotherapy-related [19]. Meanwhile, in another study of 108 patients undergoing biological reconstruction using irradiated autogenous bone grafts, there were 17 cases of early and 18 cases of late infection [15], suggesting a considerably higher rate of late infection compared with prosthetic reconstruction.
12.3.3 Risk Factors
The incidence of infection seems to be regulated by factors such as tumor site and adjuvant therapy, including neoadjuvant chemotherapy and perioperative radiotherapy. Theoretically, immunological changes due to malignancy or chemotherapy, lack of soft tissue as a result of wide resection, prolonged surgery duration, a large volume of blood loss, a large amount of avascular material in reconstruction, and radiotherapy are all risks for infection in patients with osteosarcoma. Many studies have suggested that tumor site is an obvious risk factor for infection. Figure 12.2 shows the infection rate with endoprosthesis placement in relation to tumor site [1, 24, 27, 32–37]. Here there is an obviously higher incidence of infection for the pelvis and proximal tibia. In previous reports of infection with malignant bone tumor resection, several significant risk factors for infection have been identified, although some remain controversial (Table 12.1) [1, 4, 9, 10, 15, 27, 32, 34, 37–39]. Some of these factors, such as extra-articular resection and not using a gastrocnemius flap, suggest a close relationship between SSI and a lack of soft tissue, while other factors such as skin necrosis and radiotherapy suggest that the condition of soft tissue is significant in SSI establishment.
Table 12.1
Risk factors for infection in orthopedic oncological surgery
Significant risks | References |
---|---|
Proximal tibia tumor | |
Pelvic tumor | |
Proximal femur tumor | [27] |
Chemotherapy | [37] |
Radiotherapy | |
Subsequent patellar resurfacing | [4] |
Use of extendable prosthesis | [4] |
Subsequent surgery to replace bushing | [4] |
Extra-articular resection | [27] |
Composite allograft reconstruction (vs. allograft without prosthesis) | [10] |
Not using a gastrocnemius flap (for proximal tibia tumors) | [32] |
Skin necrosis | [1] |
Prior skin infection | |
Antibiotic administration <24 h (vs. >24 h) | [9] |
Pseudarthrosis in irradiated autograft | [5] |
Nonsignificant factors | |
Age | |
Sex | |
Tumor type | |
Chemotherapy | |
Bone resection length | |
Local recurrence | [4] |
12.3.4 Clinical Characteristics
12.3.4.1 Symptoms
Common clinical symptoms of deep infection include pain, local heat, discharge/pus, local redness, and an elevation of body temperature [2]. In my previously described study, discharge/pus around the prosthesis and loosening of the endoprosthesis were detected in 56.1 % and 8.7 % of cases, respectively, and body temperature at the time of presentation ranged from 35.8 to 40.6 °C (mean, 38.3 °C; median, 38.5 °C, Fig. 12.3a) [6].
Fig. 12.3
Clinical parameters at the establishment of infection in tumor-associated endoprosthetic placement ([6] and unpublished data from T. Morii), showing (a) body temperature, (b) white blood cell count, and (c) C-reactive protein
With tumor-related endoprosthetic placement, clinical symptoms are sometimes representative of patient condition. For example, infection has been shown to occur significantly earlier in those with discharge/pus as opposed to those without and significantly later in cases with loosening of the endoprosthesis than in those without. Additionally, discharge/pus was significantly more likely among cases with extra-articular resection [6].
12.3.4.2 Laboratory Data
As for other infections, blood tests including erythrocyte sedimentation rate, C-reactive protein level, and white blood cell counts are used in the diagnosis of SSIs [40]. Grimer et al. reported an elevated erythrocyte sedimentation rate ranging from 31 to 140 mm/h (normal rate <15 mm/h) for patients with endoprosthesis-associated infections [40]. In my previous study, white blood cell counts (per mm3) ranged from 300 to 18,000 (mean, 9,023; median, 8,800) (Fig. 12.3b) [6]. However, for some immunocompromised patients undergoing systemic chemotherapy, the white blood cell number was below the normal range. In their study, Grimer et al. suggested that white blood cell count was not actually helpful, as it was above 11,000 (per mm3) for only 12 of the 34 patients [40]. C-reactive protein levels in our study ranged from 0.2 to 45.1 mg/dL (mean, 11.4 mg/dL; median, 9.0 mg/dL, Fig. 12.3c) [6]. In endoprosthesis-associated infection, analysis of synovial fluid, such as synovial fluid white blood cell counts and the calculation of neutrophil percentage, could be useful for diagnosis [41]. However, technetium bone scans, gallium scans, or white blood cell scans were reported not to be useful [40].
12.3.4.3 Pathogens
In endoprosthesis-associated infection, the infecting organism is isolated in approximately 75.4–93 % of cases [4–6], with coagulase-negative staphylococcus, Staphylococcus aureus, and Staphylococcus epidermidis infections being common [5, 6, 32, 38, 40]. Enterococci, Pseudomonas aeruginosa, Acinetobacter baumannii, Proteus mirabilis, and Streptococcus pyogenes are found to a lesser extent [5]. In my study, 37 % of S. aureus cases were methicillin resistant, and we noted that methicillin-resistant S. aureus infection is significantly associated with extra-articular resection and prolonged surgery [6].
In allograft studies, S. epidermidis, S. aureus, alpha-hemolytic streptococcus, Pseudomonas species, Enterococci, and Enterobacter species have been reported as of the most common postoperative pathogens [19].
12.3.5 Impact of Infection on Patient Outcomes
12.3.5.1 Oncological Outcomes
In general, once infection occurs during the treatment of osteosarcoma, adjuvant chemotherapy is interrupted because of its immunosuppressive effects. Thus, postoperative infection might worsen oncological outcome, especially overall survival. However, others and I have seen no association between infection and oncological outcome [1]. Interestingly, a paper by Jeys et al. reported increased survival after deep postoperative infection in osteosarcoma patients [38]. They speculated that the underlying mechanisms might include stimulation of tumor necrosis factor alpha (TNFα), tumor suppression through cell-mediated cytotoxicity, and prevention of tumor neovascularization due to infection conditions.
12.3.5.2 Limb Survival
Infections associated with endoprosthesis placement following limb salvage surgery for malignant bone tumors have been reported as a risk factor for amputation. Grimer et al. reported a risk of amputation due to infection following tumor-associated endoprosthesis placement in the proximal tibia [32]. Likewise, I have found that in addition to extracapsular resection, infection leads to an increased risk of amputation with prosthetics around the knee, although this was not found to be an independent risk factor in multivariate analysis [42].
12.3.5.3 Prosthesis Survival
Infection following endoprosthesis placement has been reported to impact prosthesis survival. Zeegen et al. reported that, along with prosthesis location, infection was an independent risk factor for prosthesis loss [31]. In my research, I have also found infection to be a significant risk for prosthesis loss [1]. In this series, resection of extended part of the quadriceps muscle, i.e., loss of soft tissue, was reported to be a risk for deep infection of the proximal femur tumor endoprosthesis. Interestingly, Hardes et al. have emphasized the importance of soft tissue condition in salvaging an infected limb along with prosthesis reconstruction, suggesting a protective role of soft tissue around the prosthesis against infection [5].
12.3.5.4 Limb Function
Zeegen et al. [31] reported that prosthesis infection was an independent risk for functional loss. I have found that functional score can be significantly different between the infected limb and the limb without infection. However, there is no clinical difference in the average scores, at 19.3 and 21.6, respectively, for patients with and without infection [42] using the Musculoskeletal Tumor Society scoring system. These findings suggest that once amputation is avoided through effective treatment of infection, there is no clinical difference in functionality.
12.4 Management
12.4.1 Prevention
12.4.1.1 General Approaches to the Prevention of Surgical Site Infection
Recently there have been many studies on the prevention of SSIs. These include studies on the administration of preoperative antimicrobial agents timed such that serum and tissue concentrations are established at the start of surgery, the implementation of glycemic control in diabetic patients to ensure perioperative blood glucose levels are <200 mg/dL [2], the maintenance of perioperative normothermia [43], and the administration of a higher fraction of inspired oxygen (FiO2) both intraoperatively and in the immediate postoperative period [44]. The findings of these studies have been incorporated into guidelines on the prevention of SSIs by the CDC and others. In general, I believe that most of these findings are relevant to infections in osteosarcoma patients. However, in some aspects, there must be differences in the pathophysiological conditions of SSI establishment between conventional orthopedic surgery and surgery for orthopedic malignancy. This is discussed in the next section.
12.4.1.2 Properties of Infections in Orthopedic Oncology
The most obvious risk for infection in osteosarcoma patients is the lack of soft tissue resulting from the wide margin used in tumor resection, and there is a large amount of evidence directly or indirectly suggesting the significance of soft tissue preservation in the management of infection. A study by Grimer et al. in 1999 on the management of proximal tibia osteosarcoma showed an infection rate of 12 % and 36 %, respectively, in cases with and without a gastrocnemius flap [32]. In a study of SSI following proximal tibia reconstruction with prosthesis due to malignancy, patients with gastrocnemius muscle flap coverage at initial surgery needed significantly fewer surgical procedures to control subsequent infection than those without a flap [6]. Thus, the routine application of a muscle flap, both with prosthetic and biological reconstruction, is currently recommended for infection control (Fig. 12.4) [10]. Likewise, in a previous study, I have shown that extended resection of the quadriceps in distal femur cases increased the risk for deep infection following prosthetic reconstruction [1]. Patients with extracompartmental resection tend to lose more soft tissue, as a larger margin is resected with the tumor. In infected patients, the final infection control rate is better for intracompartmental rather than extracompartmental resection [6]. Moreover, the risk of amputation is elevated with extracompartmental resection [6]. Although the preservation of soft tissue is practically dependent on the tumor extension, I would refer to the routine use of gastrocnemius muscle flap coverage in proximal tibia cases. In addition, if extended resection of soft tissue is required and a severe lack of soft tissue is expected due to surgery at another site, plastic surgery should be considered at the initial surgery for soft tissue coverage.
Fig. 12.4
Application of a gastrocnemius flap in the reconstruction of the proximal tibia in osteosarcoma. (a) Radiographs at presentation, (b) a wide resection of the proximal tibia followed by endoprosthetic reconstruction in a 16-year-old boy with osteosarcoma, and c gastrocnemius flap application with blood flow from the posterior tibia vessels
These findings highlight the differences in surgical conditions between oncological resection for osteosarcoma and conventional orthopedic surgery. A recent study on SSI in orthopedic surgery recommends a shorter period of single antimicrobial prophylaxis to prevent the emergence of antibiotic-resistant bacterial infection [45]. So far, there have been few studies of antimicrobial prophylaxis modality in orthopedic oncology. In 2013, Racano et al. conducted a systematic review of articles published in English between 1980 and July 2011 on clinical studies of infection rates in adults with primary bony malignancies of the lower extremities that were treated with surgery and endoprosthetic reconstruction. The pooled weighted infection rate was 13 % after short-term (<24 h) postoperative antibiotic administration and 8 % after long-term (>24 h) postoperative antibiotic administration [9], suggesting that long-term antibiotic prophylaxis reduces the risk of deep infection. Likewise, a considerably lower rate of postoperative infection with long-term antibiotic administration has been recently reported [46]. In addition, others and I have found that the use of one instead of two antibiotics during orthopedic oncological resection and endoprosthetic reconstruction surgery conferred a significant risk of amputation [6]. This shows that the prevention of SSI during conventional procedures is not always applicable to SSI in osteosarcoma surgery. Although the low case number and heterogeneity in terms of tumor location, surgery duration, tumor size, and reconstruction modality, in addition to immunological suppression in patients would make it difficult, concrete guidelines on the prevention of SSI in orthopedic oncology should be established.
12.4.2 Treatment Strategy
Surgical modalities in the control of SSIs involve the preservation of reconstruction materials, or either temporary or permanent removal of reconstruction material. As shown in Fig. 12.5, there is a large variation in the invasiveness of each modality. In general, a higher level of infection control is achieved with more invasive procedures; however, these require more time, surgical procedures, and cost and sometimes incur more functional loss than less invasive procedures. Currently, there are few principles on which to base selection of an appropriate modality. Both patients and surgeons tend to select those in which reconstruction materials such as endoprosthetics are preserved. Recent evidence shows that infection control is more effective with surgical procedures than conservative therapy, and that surgical procedures in which reconstruction material is removed are more effective than those in which it is preserved. For example, in the management of postoperative infection following limb salvage surgery with prosthetic reconstruction, prosthesis removal resulted in better infection control than conservative or prosthesis preserving therapy [4–6].
Fig. 12.5
Management modalities for surgical site infection. Surgical modalities involve either the preservation or removal of reconstruction materials. As indicated in the figure, surgery with material removal is more invasive
12.4.2.1 Conservative Therapy
Antibiotic administration is easy to perform and less invasive and is used in the management of most SSIs in the early stages of disease. As mentioned above, infection control with antibiotics alone occurs for <10 % cases with both endoprosthetic [4] and biological reconstruction (Table 12.2) [10, 12–14, 19, 47–49]; however, for both patients and surgeons, this is the best option. Thus, I analyzed the properties of cases from a previous study with tumor-associated endoprosthetic reconstruction around the knee, in which conservative therapy was effective in SSI control, and found that conservative therapy was significantly more successful in cases with prostheses in the tibia than the femur and more successful in cases without discharge/pus at infection presentation [6]. In addition, Hardes et al. reviewed 30 such patients and found that only one patient with a late, low-grade infection could be treated successfully with intravenous antibiotics [5]. In biological reconstruction, surface infection is more successfully controlled by conservative therapy [14, 47].
Table 12.2
Successful modalities for the control of surgical site infection following biological reconstruction